U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C30H40N4.2C7H5O3
Molecular Weight 730.891
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DEQUALINIUM SALICYLATE

SMILES

OC1=CC=CC=C1C([O-])=O.OC2=CC=CC=C2C([O-])=O.CC3=CC(N)=C4C=CC=CC4=[N+]3CCCCCCCCCC[N+]5=C(C)C=C(N)C6=CC=CC=C56

InChI

InChIKey=KJKANYXQJTTYMC-UHFFFAOYSA-N
InChI=1S/C30H38N4.2C7H6O3/c1-23-21-27(31)25-15-9-11-17-29(25)33(23)19-13-7-5-3-4-6-8-14-20-34-24(2)22-28(32)26-16-10-12-18-30(26)34;2*8-6-4-2-1-3-5(6)7(9)10/h9-12,15-18,21-22,31-32H,3-8,13-14,19-20H2,1-2H3;2*1-4,8H,(H,9,10)

HIDE SMILES / InChI

Molecular Formula C7H6O3
Molecular Weight 138.1207
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C30H38N4
Molecular Weight 454.6495
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including https://www.drugs.com/uk/fluomizin-10-mg-vaginal-tablets-leaflet.html | https://www.drugs.com/pro/salicylic-acid.html

Dequalinium salicylate is a bisquanternary quinolinium antiseptic which kills many gram-positive and gram-negative bacteria. Dequalinium Salicylate have antibacterial (mediated by Dequalinium action) and anti-inflammatory activities (mediated by Salicylic acid action). Dequalinium has an antiseptic effect against a wide range of bacteria, yeasts, and some fungi and viruses. It kills the micro-organisms associated with various mild infections of the mouth and throat. Salicylic acid have direct anti-inflammatory activity mediated by inhibition of both types of cyclo-oxygenases (COX-1 and COX-2) to decrease the formation of precursors of prostaglandins and thromboxanes from arachidonic acid.

Originator

Sources: JP41018231

Approval Year

TargetsConditions
PubMed

PubMed

TitleDatePubMed
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Topical
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:30:32 GMT 2025
Edited
by admin
on Mon Mar 31 19:30:32 GMT 2025
Record UNII
65A568ZIJ4
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DEQUALINIUM SALICYLATE
WHO-DD  
Common Name English
DEQUALINIUM SALYCILATE
JAN  
Preferred Name English
DEQUALINIUM SALYCILATE [JAN]
Common Name English
SALICYLIC ACID, ION(1-), 1,1'-DECAMETHYLENEBIS(4-AMINOQUINALDINIUM)
Common Name English
QUINOLINIUM, 1,1'-(1,10-DECANEDIYL)BIS(4-AMINO-2-METHYL-, 2-HYDROXYBENZOATE (1:2)
Common Name English
Dequalinium salicylate [WHO-DD]
Common Name English
Code System Code Type Description
ECHA (EC/EINECS)
240-157-4
Created by admin on Mon Mar 31 19:30:32 GMT 2025 , Edited by admin on Mon Mar 31 19:30:32 GMT 2025
PRIMARY
RXCUI
236549
Created by admin on Mon Mar 31 19:30:32 GMT 2025 , Edited by admin on Mon Mar 31 19:30:32 GMT 2025
PRIMARY RxNorm
EVMPD
SUB01592MIG
Created by admin on Mon Mar 31 19:30:32 GMT 2025 , Edited by admin on Mon Mar 31 19:30:32 GMT 2025
PRIMARY
FDA UNII
65A568ZIJ4
Created by admin on Mon Mar 31 19:30:32 GMT 2025 , Edited by admin on Mon Mar 31 19:30:32 GMT 2025
PRIMARY
CAS
16022-70-1
Created by admin on Mon Mar 31 19:30:32 GMT 2025 , Edited by admin on Mon Mar 31 19:30:32 GMT 2025
PRIMARY
EPA CompTox
DTXSID60166838
Created by admin on Mon Mar 31 19:30:32 GMT 2025 , Edited by admin on Mon Mar 31 19:30:32 GMT 2025
PRIMARY
PUBCHEM
54683736
Created by admin on Mon Mar 31 19:30:32 GMT 2025 , Edited by admin on Mon Mar 31 19:30:32 GMT 2025
PRIMARY
SMS_ID
100000087754
Created by admin on Mon Mar 31 19:30:32 GMT 2025 , Edited by admin on Mon Mar 31 19:30:32 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
PARENT -> SALT/SOLVATE